To describe the morphologic features of Fuchs corneal dystrophy and compare them with those of bullous keratopathy.
This was an observational case series. The study group consisted of 32 corneal buttons with a diagnosis of Fuchs dystrophy and the comparison group consisted of 22 corneal buttons with bullous keratopathy. Morphologic analysis was performed of corneal buttons from patients with the clinical diagnosis of Fuchs dystrophy or bullous keratopathy by light and electron microscopy.
The main outcome measure was identification of degenerated keratocytes, granular material in and around keratocytes, and lipid keratopathy. The overall morphologic features of Fuchs dystrophy and bullous keratopathy are similar to those described in previous literature. A high proportion of keratocytes exhibited degenerative changes (78.9% in Fuchs dystrophy versus 50.5% in bullous keratopathy). Granular material was identified in and around variably degenerated keratocytes in all cases of Fuchs dystrophy and in 14 of 22 (64%) of the corneas with bullous keratopathy. The percentage of keratocytes with granular deposits was higher in Fuchs dystrophy corneas as compared with corneas with bullous keratopathy (51.7% versus 14.1%, P < 0.0005). Lipid keratopathy was a common occurrence in both Fuchs dystrophy and bullous keratopathy (23/32 [72%] versus 12/22 [55%]).
Histopathologic changes in the corneal stroma and keratocytes occur in Fuchs dystrophy. Secondary lipid keratopathy ensues and may contribute to corneal haze. A higher proportion of keratocytes in Fuchs dystrophy have granular deposit than in bullous keratopathy. That a high proportion of keratocytes had degenerative changes in both Fuchs dystrophy and bullous keratopathy suggests that keratocytes may degenerate secondary to altered stromal microenvironment because of endothelial cell loss.
From the *Eye Pathology Laboratory, Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD; and †Cornea Service, Wilmer Institute, The Johns Hopkins Medical Institutions, Baltimore, MD.
Received for publication December 23, 2002; Revision received July 14, 2004; accepted July 17, 2004.
Supported in part by The Sir Robert Black Trust Fund and the Hong Kong Eye Hospital (Dr. Yuen), the Wilmer Institute Shupiro Fund (Dr. Rassier), and the Independent Order of Odd Fellows, Winston-Salem, NC (Dr. Green).
Reprints: W. Richard Green, MD, The Johns Hopkins Hospital, Eye Pathology Laboratory/Maumenee Building 427, 600 N. Wolfe Street, Baltimore, MD 21287-9248 (e-mail: email@example.com).